These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3904355)

  • 21. Immunofluorescent studies of complement C3 in the hair follicles of normal scalp and of scalp affected by alopecia areata.
    Igarashi R; Takeuchi S; Sato Y
    Acta Derm Venereol; 1980; 60(1):33-7. PubMed ID: 6153831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diphencyprone in the treatment of alopecia areata.
    Happle R; Hausen BM; Wiesner-Menzel L
    Acta Derm Venereol; 1983; 63(1):49-52. PubMed ID: 6191489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A study of HLA antigens and immune response to DNCB in alopecia areata.
    Van Neste D; Szapiro E; Breuillard F; Goudemand J
    Clin Exp Dermatol; 1980 Dec; 5(4):389-94. PubMed ID: 7261458
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lymphocytes in alopecia areata].
    Szczeklik-Franek A; Musiałowicz D; Włoszczuk-Szulc H; Huzarski J
    Przegl Dermatol; 1981; 68(4):447-51. PubMed ID: 6977139
    [No Abstract]   [Full Text] [Related]  

  • 25. Differential T-cell reactivity to the round and oval forms of Pityrosporum in the skin of patients with psoriasis.
    Baker BS; Powles A; Garioch JJ; Hardman C; Fry L
    Br J Dermatol; 1997 Mar; 136(3):319-25. PubMed ID: 9115908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of alopecia areata by immunostimulation with dinitrochlorobenzene].
    Wasik F; Blizanowska A; Cisło M; Janas M
    Przegl Dermatol; 1981; 68(1):79-83. PubMed ID: 7244264
    [No Abstract]   [Full Text] [Related]  

  • 27. [Suggestion for dinitrochlorobenzene treatment of alopecia areata].
    Happle R
    Z Hautkr; 1979 Oct; 54(19):866. PubMed ID: 524976
    [No Abstract]   [Full Text] [Related]  

  • 28. In situ lymphocyte subsets in alopecia areata before and during treatment with a contact allergen.
    Baadsgaard O; Lindskov R; Clemmensen OJ
    Clin Exp Dermatol; 1987 Jul; 12(4):260-4. PubMed ID: 3427805
    [No Abstract]   [Full Text] [Related]  

  • 29. The protective role of the HLA-DR locus in patients with various clinical types of alopecia areata.
    Broniarczyk-Dyła G; Prusińska-Bratoś M; Dubla-Berner M; Arkuszewska C; Borowiec M; Kowalski ML; Woszczek G
    Arch Immunol Ther Exp (Warsz); 2002; 50(5):333-6. PubMed ID: 12455867
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood lymphocyte subpopulations and antibody dependent, cell-mediated cytotoxicity (ADCC) in alopecia areata and universalis.
    Gu SQ; Ros AM; Thyresson N; Wasserman J
    Acta Derm Venereol; 1981; 61(2):125-9. PubMed ID: 6165187
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine Targeted Therapeutics for Alopecia Areata: Lessons from Atopic Dermatitis and Other Inflammatory Skin Diseases.
    Malik K; Guttman-Yassky E
    J Investig Dermatol Symp Proc; 2018 Jan; 19(1):S62-S64. PubMed ID: 29273110
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alopecia areata, clinical and immunological aspects].
    van Joost T; Peereboom-Wynia JD; Stolz E; Prins ME
    Ned Tijdschr Geneeskd; 1987 Mar; 131(13):519-23. PubMed ID: 3574510
    [No Abstract]   [Full Text] [Related]  

  • 33. Antigenic competition as a therapeutic concept for alopecia areata.
    Happle R
    Arch Dermatol Res; 1980; 267(1):109-14. PubMed ID: 6446265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Topical treatment of alopecia areata.
    Swanson NA; Mitchell AJ; Leahy MS; Headington JT; Diaz LA
    Arch Dermatol; 1981 Jul; 117(7):384-7. PubMed ID: 7259216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unusual response to DNCB contact sensitivity in an atopic patient with alopecia areata.
    Valsecchi R; Cainelli T
    Contact Dermatitis; 1982 May; 8(3):206. PubMed ID: 7094577
    [No Abstract]   [Full Text] [Related]  

  • 36. Alopecia areata: immunofluorescence and other studies.
    Klaber MR; Munro DD
    Br J Dermatol; 1978 Oct; 99(4):383-6. PubMed ID: 708610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Allergological reactivity in alopecia areata].
    Tonkin N; Petrunov B; Konstantinova D; Stanoeva E
    Vestn Dermatol Venerol; 1980 Sep; (9):6-10. PubMed ID: 7424163
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic synergy between contact dermatitis from a wig-fixing device and tofacitinib on alopecia areata.
    Lee JS; Yoon HS; Cho S; Park HS
    J Dermatol; 2019 Apr; 46(4):e139-e140. PubMed ID: 30204259
    [No Abstract]   [Full Text] [Related]  

  • 39. What can the genetics of psoriasis teach us about alopecia areata?
    Elder JT
    J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S34-6. PubMed ID: 24326547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunofluorescence studies on complement components in the hair follicles of normal scalp and of scalp affected by alopecia areata.
    Igarashi R; Morohashi M; Takeuchi S; Sato Y
    Acta Derm Venereol; 1981; 61(2):131-5. PubMed ID: 6165188
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.